HUT77811A - Permetezve szárított eritropoietin - Google Patents

Permetezve szárított eritropoietin

Info

Publication number
HUT77811A
HUT77811A HU9800996A HU9800996A HUT77811A HU T77811 A HUT77811 A HU T77811A HU 9800996 A HU9800996 A HU 9800996A HU 9800996 A HU9800996 A HU 9800996A HU T77811 A HUT77811 A HU T77811A
Authority
HU
Hungary
Prior art keywords
spray dried
erythropoietin
dried erythropoietin
rhepo
provides
Prior art date
Application number
HU9800996A
Other languages
English (en)
Other versions
HU222370B1 (hu
Inventor
Diane C. Corbo
Khurshid Iqbal
Deepak B. Mehta
Original Assignee
Ortho Pharmaceutical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23407689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT77811(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corporation filed Critical Ortho Pharmaceutical Corporation
Publication of HUT77811A publication Critical patent/HUT77811A/hu
Publication of HU222370B1 publication Critical patent/HU222370B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
HU9800996A 1994-12-16 1995-12-15 Permetezve szárított eritropoietin HU222370B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35794794A 1994-12-16 1994-12-16
PCT/US1995/016416 WO1996018647A1 (en) 1994-12-16 1995-12-15 Spray dried erythropoietin

Publications (2)

Publication Number Publication Date
HUT77811A true HUT77811A (hu) 1998-08-28
HU222370B1 HU222370B1 (hu) 2003-06-28

Family

ID=23407689

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800996A HU222370B1 (hu) 1994-12-16 1995-12-15 Permetezve szárított eritropoietin

Country Status (19)

Country Link
US (2) US6001800A (hu)
EP (1) EP0805822B2 (hu)
JP (1) JP4039686B2 (hu)
CN (1) CN1117762C (hu)
AT (1) ATE265468T1 (hu)
AU (1) AU697287B2 (hu)
CA (1) CA2207615C (hu)
DE (1) DE69532970T3 (hu)
DK (1) DK0805822T4 (hu)
ES (1) ES2219672T5 (hu)
FI (1) FI119723B (hu)
HU (1) HU222370B1 (hu)
IL (1) IL116085A (hu)
NO (1) NO319895B1 (hu)
NZ (1) NZ298981A (hu)
PT (1) PT805822E (hu)
TW (1) TW425287B (hu)
WO (1) WO1996018647A1 (hu)
ZA (1) ZA9510708B (hu)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6151332A (en) 1997-06-20 2000-11-21 Tantivy Communications, Inc. Protocol conversion and bandwidth reduction technique providing multiple nB+D ISDN basic rate interface links over a wireless code division multiple access communication system
US6081536A (en) 1997-06-20 2000-06-27 Tantivy Communications, Inc. Dynamic bandwidth allocation to transmit a wireless protocol across a code division multiple access (CDMA) radio link
US6542481B2 (en) 1998-06-01 2003-04-01 Tantivy Communications, Inc. Dynamic bandwidth allocation for multiple access communication using session queues
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
US6222832B1 (en) 1998-06-01 2001-04-24 Tantivy Communications, Inc. Fast Acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system
US9525923B2 (en) 1997-12-17 2016-12-20 Intel Corporation Multi-detection of heartbeat to reduce error probability
US7394791B2 (en) 1997-12-17 2008-07-01 Interdigital Technology Corporation Multi-detection of heartbeat to reduce error probability
US7496072B2 (en) 1997-12-17 2009-02-24 Interdigital Technology Corporation System and method for controlling signal strength over a reverse link of a CDMA wireless communication system
US7936728B2 (en) 1997-12-17 2011-05-03 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US8134980B2 (en) 1998-06-01 2012-03-13 Ipr Licensing, Inc. Transmittal of heartbeat signal at a lower level than heartbeat request
US7773566B2 (en) 1998-06-01 2010-08-10 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US6526034B1 (en) 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
AU3673001A (en) 2000-02-07 2001-08-14 Tantivy Communications, Inc. Minimal maintenance link to support synchronization
US8155096B1 (en) 2000-12-01 2012-04-10 Ipr Licensing Inc. Antenna control system and method
US7551663B1 (en) 2001-02-01 2009-06-23 Ipr Licensing, Inc. Use of correlation combination to achieve channel detection
US6954448B2 (en) 2001-02-01 2005-10-11 Ipr Licensing, Inc. Alternate channel for carrying selected message types
JP2005501801A (ja) * 2001-02-02 2005-01-20 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド フラクトピラノーススルファメートとエリスロポイエチンを含んで成る神経学的機能不全治療
KR100665077B1 (ko) 2001-06-13 2007-01-09 탄티비 커뮤니케이션즈 인코포레이티드 하트비트 요구보다 낮은 레벨로의 하트비트 신호의 전송
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
WO2004060343A1 (en) * 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions
JP4745826B2 (ja) 2003-11-14 2011-08-10 中外製薬株式会社 架橋多糖微粒子およびその製造方法
CA2927595C (en) 2004-12-22 2023-01-31 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CN103690936A (zh) 2004-12-22 2014-04-02 Ambrx公司 经修饰的人类生长激素
AU2006315347A1 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CA2663083A1 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
EP2120998B1 (en) 2006-11-28 2013-08-07 HanAll Biopharma Co., Ltd. Modified erythropoietin polypeptides and uses thereof for treatment
WO2008121563A2 (en) 2007-03-30 2008-10-09 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
NZ580686A (en) 2007-05-02 2012-11-30 Ambrx Inc Modified interferon beta polypeptides and their uses
AU2009204863B2 (en) * 2008-01-15 2015-07-16 AbbVie Deutschland GmbH & Co. KG Powdered protein compositions and methods of making same
EP3225248B1 (en) 2008-07-23 2023-06-07 Ambrx, Inc. Modified bovine g-csf polypeptides and their uses
PT104350A (pt) * 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CN104017063A (zh) 2009-12-21 2014-09-03 Ambrx公司 经过修饰的猪促生长素多肽和其用途
MX349301B (es) 2009-12-21 2017-07-21 Ambrx Inc Polipéptidos de somatotropina bovina modificados y sus usos.
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CA2823628A1 (en) 2011-01-05 2012-07-12 Hospira, Inc. Spray drying vancomycin
WO2013126552A1 (en) 2012-02-21 2013-08-29 Auburn University Buprenorphine nanoparticle composition and methods thereof
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
MX2017004947A (es) 2014-10-24 2017-06-29 Bristol Myers Squibb Co Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
CN104984323B (zh) * 2015-06-12 2018-05-01 北京四环生物制药有限公司 注射用重组人促红素冻干粉针剂
CN105311624A (zh) * 2015-11-23 2016-02-10 哈药集团生物工程有限公司 一种含有重组人促红素的药物组合物
KR20210057124A (ko) 2018-09-11 2021-05-20 암브룩스, 인코포레이티드 인터류킨-2 폴리펩타이드 접합체 및 그의 용도
AU2019361206A1 (en) 2018-10-19 2021-06-03 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
AU2020223031A1 (en) 2019-02-12 2021-08-19 Ambrx, Inc. Compositions containing, methods and uses of antibody-TLR agonist conjugates
CN115243726A (zh) 2020-03-11 2022-10-25 北京泰德制药股份有限公司 白介素-2多肽偶联物及其使用方法
EP4199968A1 (en) 2020-08-20 2023-06-28 Ambrx, Inc. Antibody-tlr agonist conjugates, methods and uses thereof
MX2023011480A (es) 2021-04-03 2023-12-06 Ambrx Inc Conjugados anticuerpo anti-her2-fármaco y usos de estos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin

Also Published As

Publication number Publication date
PT805822E (pt) 2004-08-31
NO319895B1 (no) 2005-09-26
ZA9510708B (en) 1997-06-17
CA2207615C (en) 2010-12-14
FI119723B (fi) 2009-02-27
MX9704504A (es) 1998-06-30
EP0805822A1 (en) 1997-11-12
US6235710B1 (en) 2001-05-22
JPH10511087A (ja) 1998-10-27
DE69532970T3 (de) 2012-02-09
IL116085A0 (en) 1996-01-31
DK0805822T3 (da) 2004-08-16
WO1996018647A1 (en) 1996-06-20
NO972725D0 (no) 1997-06-13
EP0805822B1 (en) 2004-04-28
ES2219672T3 (es) 2004-12-01
ATE265468T1 (de) 2004-05-15
JP4039686B2 (ja) 2008-01-30
EP0805822B2 (en) 2011-06-15
AU697287B2 (en) 1998-10-01
FI972557A (fi) 1997-08-14
AU4471396A (en) 1996-07-03
FI972557A0 (fi) 1997-06-16
DE69532970D1 (en) 2004-06-03
CA2207615A1 (en) 1996-06-20
DE69532970T2 (de) 2005-06-09
HU222370B1 (hu) 2003-06-28
DK0805822T4 (da) 2011-07-11
CN1117762C (zh) 2003-08-13
IL116085A (en) 1999-12-31
NZ298981A (en) 1999-11-29
TW425287B (en) 2001-03-11
NO972725L (no) 1997-08-06
ES2219672T5 (es) 2011-09-26
CN1175261A (zh) 1998-03-04
US6001800A (en) 1999-12-14

Similar Documents

Publication Publication Date Title
DE69532970D1 (en) Sprühgetrocknetes erythropoietin
EP0702040A3 (hu)
HK1010196A1 (en) Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives.
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
AU1148099A (en) Powder varnish composition, method for producing and the use thereof
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
AU4278897A (en) 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds
IL126989A0 (en) Process for making 4,6-dihydroxypyrimidine
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
AU2316897A (en) Cyclic imido-1,3,5-triazine crosslinking agents
ZA962753B (en) 1,3-Dihydro-2H-imidazol-2-one derivatives.
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
EP0653466A3 (en) Powder coating.
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
EP0653246A3 (en) Atomizer.
EP0694538A3 (en) 2-Benzyloxy-4-phenoxy pyrimidine derivatives, process for their preparation and herbicidal compositions containing them
AU7570798A (en) Ionic halomethyl-1,3,5-triazine photoinitiators
ZA978831B (en) Stable, one package coating compositions and process for coating.
EP0680790A3 (en) Powder nozzle.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
AU1568895A (en) Process for preparing 2,6-dichloropyridine
AU4715196A (en) Desaminononapeptides, process for preparing the same and their use for preparing elcatonin
AU7035998A (en) New thiazoledinediones, method for the production thereof, and medicaments containing the same
ZA991215B (en) Process for the preparation of 1,3-disubstituted 2-nitroguanidines.
NO902138D0 (no) Fremgangsmaate for pulverbelegging.

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20030407